title: Time to rethink clinically important outcomes in platelet transfusion trials.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, Ontario, Canada. heddlen@mcmaster.ca
authors.forename: Nancy M
authors.initials: NM
authors.lastname: Heddle
authors.forename: Donald M
authors.initials: DM
authors.lastname: Arnold
authors.forename: Kathryn E
authors.initials: KE
authors.lastname: Webert
mesh_terms: D015415:Biomarkers; D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data*; D006470:Hemorrhage / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D017713:Platelet Transfusion; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D012107:Research Design; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014944:World Health Organization
chemical_list: D015415:Biomarkers